Gotham Asset Management, LLC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$65,000
-58.6%
11,431
-48.2%
0.00%
-60.0%
Q2 2022$157,000
-30.5%
22,053
-29.4%
0.01%
-28.6%
Q1 2022$226,000
-13.4%
31,254
+7.1%
0.01%
-12.5%
Q4 2021$261,000
-83.1%
29,184
-33.8%
0.01%
-87.3%
Q3 2021$1,546,000
+222.1%
44,095
+97.2%
0.06%
+215.0%
Q2 2021$480,00022,3650.02%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 1,265,631$27,186,00091.01%
Yu Fan 143,867$3,090,00034.92%
AJU IB Investment Co., Ltd. 1,745,331$37,490,00021.62%
Bain Capital Life Sciences Investors, LLC 5,615,659$120,624,0007.90%
Cormorant Asset Management, LP 6,411,355$137,716,0004.68%
Ally Bridge Group (NY) LLC 373,288$8,018,0001.99%
RA Capital Management 5,368,451$115,314,0001.85%
Omega Fund Management, LLC 746,868$16,043,0001.82%
CM Management, LLC 90,000$1,933,0001.40%
SECTORAL ASSET MANAGEMENT INC 538,884$11,575,0000.94%
View complete list of ATEA PHARMACEUTICALS INC shareholders